Overview

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

Status:
Completed
Trial end date:
2012-10-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out why women's arteries stiffen as they go through menopause, and how this is affected by estrogen loss. We believe that arteries stiffen with the loss of estrogen because of "oxidative stress," the production of molecules that can damage cells and tissues in the body, and because the arteries lose their ability to expand, or dilate.
Phase:
N/A
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute on Aging (NIA)
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Ganirelix
LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-
Polyestradiol phosphate